Press Releases

 
seek and you will find

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer Early Detection at the 2025 Early Detection of Cancer Conference

October 20, 2025 · Press Releases

Portland, Oregon — October 20, 2025 — SeekIn Inc., a leader in liquid biopsy-based cancer...

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, Affordable AI Blood Test for Multi-Cancer Early Detection

October 9, 2025 · Press Releases

San Diego, USA — October 9, 2025 — SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn Expanding Lung Cancer Screening With Low-Cost Blood Test

October 7, 2025 · Media Resources

NEW YORK - October 7, 2025 - Bolstered by recent study results, cancer diagnostics firm SeekIn is...

LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

October 1, 2025 · Media Resources

San Diego, USA – October 1, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn’s OncoSeek® test Recognized in China’s Expert Consensus on Multi-Cancer Early Detection

August 8, 2025 · Press Releases

Shenzhen, China - August 7, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn Secures Five U.S. Trademarks for Breakthrough Cancer Diagnostic Tests, Capping Global IP Expansion

July 27, 2025 · Press Releases

San Diego, July 28, 2025 - SeekIn Inc., a leader in blood-based early cancer detection and...

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

July 3, 2025 · Media Resources

San Diego, July 2, 2025 -- A new prospective study published in BMC Cancer demonstrates that a...

Accelerating early cancer detection in Latin America: Biotecgen enters strategic partnership with OncoInv

June 18, 2025 · Media Resources

San Diego, June 18, 2025 -- Biotecgen (Colombia) and OncoInv (The Netherlands) have joined forces...

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

June 2, 2025 · Media Resources

San Diego, May 26, 2025 -- A groundbreaking study published in the Journal of Molecular...

SeekIn to Present Cancer Early Detection Technologies at the 2025 ASCO Annual Meeting

May 30, 2025 · Press Releases

CHICAGO, United States, May 30, 2025 - SeekIn Inc., a leader in blood-based cancer early...

From Non-Invasive Early Detection to Treatment Response Monitoring: SeekIn Presents Three Innovative Technologies at EUROMEDLAB 2025

May 20, 2025 · Press Releases

Brussels, Belgian - May 18-22, 2025 SeekIn Inc., a leader in blood-based cancer early detection...

2025 European Debut: SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at NKI Early Cancer Detection Conference

May 15, 2025 · Press Releases

Amsterdam, the Netherlands - May 14-15, 2025 SeekIn Inc., a leader in blood-based cancer early...

All Categories - SeekIn

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer Early Detection at the 2025 Early Detection of Cancer Conference

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, Affordable AI Blood Test for Multi-Cancer Early Detection

SeekIn Expanding Lung Cancer Screening With Low-Cost Blood Test

LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

SeekIn’s OncoSeek® test Recognized in China’s Expert Consensus on Multi-Cancer Early Detection

SeekIn Secures Five U.S. Trademarks for Breakthrough Cancer Diagnostic Tests, Capping Global IP Expansion

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

Accelerating early cancer detection in Latin America: Biotecgen enters strategic partnership with OncoInv

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

SeekIn to Present Cancer Early Detection Technologies at the 2025 ASCO Annual Meeting

From Non-Invasive Early Detection to Treatment Response Monitoring: SeekIn Presents Three Innovative Technologies at EUROMEDLAB 2025

2025 European Debut: SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at NKI Early Cancer Detection Conference

Longevity Medical Institute™ Integrates OncoSeek® to Launch One of Mexico's Most Advanced Cancer Screening Programs

BIOS and OncoInv have joined in partnership to bring cancer detection to Pakistan

SeekIn's Two-Step Multi-Cancer Early Detection Method May Reduce False Positives, Screening Costs

SeekIn Publishes A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection

SeekIn Publishes Innovative SeekInCure Test for Early Detection of Minimal Residual Disease in Liver Cancer Patients

SeekIn Presents Two Revolutionary Innovations at AACR Liquid Biopsy Conference

SeekIn CEO's Vision: Bridging Gaps for Equitable Healthcare in Impoverished Communities

OncoSeek®: Narrowing the Healthcare Gap and Making Early Screening Accessible

SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.

Newsroom

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer...

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, ...

SeekIn Expanding Lung Cancer Screening With Low-Cost Blood Test

LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection...

SeekIn’s OncoSeek® test Recognized in China’s Expert Consensus on ...

SeekIn Secures Five U.S. Trademarks for Breakthrough Cancer Diagnostic...